Latest news with #Mehta
Business Recorder
a day ago
- Business
- Business Recorder
Indian rapeseed meal exports soar as China replaces Canadian supply
MUMBAI: China is set to make record purchases of rapeseed meal from India following Beijing's move to impose a 100% retaliatory tariff on Canadian imports, senior industry officials said. India's rapeseed meal exports will help China, the world's top consumer, replace imports from Canada while easing pressure on local rapeseed prices in India where there are large stockpiles of the widely used animal feed. 'Indian rapeseed meal is very competitive compared to other origins. That's why China has been increasing purchases since March,' B.V. Mehta, executive director of the Solvent Extractors' Association of India, told Reuters. India's rapeseed meal exports to China are likely to jump to a record 500,000 metric tons in the 2025/26 marketing year which started in April, up from the last year's 60,759 tons, Mehta said. In the first two months of 2025/26, India exported 113,836 tons of rapeseed meal to China, which imposed a 100% retaliatory tariff on rapeseed meal and oil imports from Canada starting on March 20. In 2024, China imported 2.02 million metric tons of rapeseed meal from Canada, 504,000 tons from the United Arab Emirates, and 135,000 tons from Russia, according to customs data. It bought 13,100 tons from India. China allows imports of rapeseed meal, soybean meal from Uruguay India, the world's third-largest rapeseed producer, had struggled to export significant amounts of rapeseed meal to China because of higher prices in the past. But now India is offering rapeseed meal at around $202 per ton on a free-on-board (FOB) basis compared to around $300 for supplies from the European Union, traders said. 'China has emerged as the biggest buyer of Indian rapeseed meal from nowhere. It is buying more than 50,000 tons every month,' said one of the leading exporters. South Korea, Bangladesh, Thailand, and Vietnam traditionally account for the bulk of India's rapeseed meal exports. India badly needs edible oils to fulfill local demand amid lower imports in the past few months, said the exporter. 'Higher rapeseed crushing because of Chinese demand for meal is improving rapeseed oil supplies,' he said. India, the world's biggest importer of vegetable oils, buys palm oil mainly from Indonesia and Malaysia, while it imports soyoil and sunflower oil from Argentina, Brazil, Russia and Ukraine.
Time of India
a day ago
- Business
- Time of India
Indian rapeseed meal exports soar as China replaces Canadian supply
China is set to make record purchases of rapeseed meal from India following Beijing's move to impose a 100% retaliatory tariff on Canadian imports, senior industry officials said. India's rapeseed meal exports will help China, the world's top consumer, replace imports from Canada while easing pressure on local rapeseed prices in India where there are large stockpiles of the widely used animal feed. "Indian rapeseed meal is very competitive compared to other origins. That's why China has been increasing purchases since March," B.V. Mehta , executive director of the Solvent Extractors' Association of India , told Reuters. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy Brass Idols - Handmade Brass Statues for Home & Gifting Luxeartisanship Buy Now Undo India's rapeseed meal exports to China are likely to jump to a record 500,000 metric tons in the 2025/26 marketing year which started in April, up from the last year's 60,759 tons, Mehta said. In the first two months of 2025/26, India exported 113,836 tons of rapeseed meal to China, which imposed a 100% retaliatory tariff on rapeseed meal and oil imports from Canada starting on March 20. Live Events In 2024, China imported 2.02 million metric tons of rapeseed meal from Canada, 504,000 tons from the United Arab Emirates, and 135,000 tons from Russia, according to customs data. It bought 13,100 tons from India. India, the world's third-largest rapeseed producer, had struggled to export significant amounts of rapeseed meal to China because of higher prices in the past. But now India is offering rapeseed meal at around $202 per ton on a free-on-board (FOB) basis compared to around $300 for supplies from the European Union, traders said. "China has emerged as the biggest buyer of Indian rapeseed meal from nowhere. It is buying more than 50,000 tons every month," said one of the leading exporters. South Korea, Bangladesh, Thailand, and Vietnam traditionally account for the bulk of India's rapeseed meal exports. India badly needs edible oils to fulfill local demand amid lower imports in the past few months, said the exporter. "Higher rapeseed crushing because of Chinese demand for meal is improving rapeseed oil supplies," he said. India, the world's biggest importer of vegetable oils, buys palm oil mainly from Indonesia and Malaysia, while it imports soyoil and sunflower oil from Argentina, Brazil, Russia and Ukraine.
Campaign ME
2 days ago
- Business
- Campaign ME
Gaming adtech company Napptix acquires Yazle's MENA business
Napptix, a Dubai-based ad-tech company behind the Gaming 360° advertising platform, has completed its acquisition of Yazle Marketing Management's Middle-East & North-Africa (MENA) business. The agreement covers Yazle's commercial activities, client portfolio and team across the Gulf and North Africa, Yazle's businesses in Asia-Pacific, Europe and the Americas continue under existing ownership. Bringing Yazle's regional client portfolio and experienced team into Napptix aims to strengthen its ability to deliver culturally relevant, measurable gaming-media solutions across the GCC. 'This isn't just an acquisition – it's an alignment of vision,' said Saurabh Mehta, Co-Founder and General Manager of Napptix. 'We're building a future where advertising is seamlessly embedded into our region's gaming culture. With Yazle MENA's expertise and Napptix's proprietary technology, we're creating the most emotionally intelligent, context-aware and brand-safe media offering in the MENA region.' Mehta further explained the move is a result of the prevalence of gaming as an advertising channel. 'As mobile gaming continues to outpace other digital channels in user engagement and mood-positive environments, this acquisition positions Napptix as the go-to GamingTech platform for brands seeking meaningful, measurable impact through innovative, playable, immersive gaming advertisements in the MENA market,' Mehta said. For Yazle, the sale allows focus on its other international hubs and product innovation roadmap. 'Yazle has evolved into a multi-region organisation,' said Gaurav Aidasani, Co-Founder of Yazle. 'As we sharpen our focus on international growth, we're confident our MENA clients and team will thrive within Napptix's gaming-first ecosystem – built from the ground up to deliver brand-safe, immersive media experiences.' Jamie Atherton will continue to lead the regional business as Managing Director, Yazle Middle East & North Africa. He deemed the acquisition as 'a major leap forward' and a 'strategic consolidation of strengths'. 'Yazle MENA has always stood for innovation and excellence in gaming and digital advertising,' Atherton said. 'Partnering with Napptix – whose tech-first approach and gamer-centric ecosystem are unmatched – opens new possibilities for our clients to connect with Gen Z and gaming-heavy audiences in the GCC and beyond in smarter, more immersive ways.'
Techday NZ
3 days ago
- Business
- Techday NZ
Secureframe unveils Custom Integrations for complex IT compliance
Secureframe has announced the launch of Custom Integrations, a capability enabling organisations to integrate data from any source into its compliance management platform. The new feature is designed to support companies with complex IT environments, including those utilising legacy systems, custom applications, and on-premise infrastructure. Previously, such organisations faced challenges automating compliance processes when using technology stacks that could not be connected through Secureframe's standard integrations. Secureframe currently provides more than 300 native integrations with various tools and systems. Custom Integrations is intended to remove limitations by allowing data ingestion, normalisation, and continuous monitoring from any system using API endpoints or CSV uploads. Shrav Mehta, Chief Executive Officer at Secureframe, commented on the changing needs of businesses managing compliance in intricate environments: "The compliance landscape has evolved far beyond one-size-fits-all solutions. Many enterprises have told us they love our automation capabilities but need support for their unique tech stacks. Custom Integrations represents a fundamental shift in how we approach compliance automation — instead of asking organisations to adapt to our platform, we're enabling our platform to adapt to them." According to Secureframe, the new capability is aimed at directly addressing the compliance difficulties encountered by organisations with sophisticated or unique IT environments. Several features have been introduced as part of Custom Integrations. Features detailed The capability includes automated schema detection, enabling Secureframe to automatically identify resource types and map data fields, thereby reducing manual work for developers. Organisations are able to define custom data models, specifying mandatory and optional fields for each resource type, and have the flexibility to edit as requirements evolve. Teams can utilise self-service debugging features, with clear error messages and request logs to support troubleshooting without requiring external support. Custom Integrations also includes a no-code editor for the creation of automated tests, supporting continuous compliance monitoring across all integrated systems and data sources. Ingested data from any source is normalised and organised within Secureframe's unified asset inventory, providing centralised management. Mehta added further context about the broader trend affecting enterprises and Secureframe's aim to address it: "We're seeing a clear trend where enterprises need compliance solutions that can scale with their complexity, not despite it. Custom Integrations goes beyond solving a technical problem to unlock a new level of compliance automation that was previously impossible for organisations with diverse IT environments." Expanded automation scope Custom Integrations is positioned to extend Secureframe's automation coverage by incorporating data from previously unsupported systems. Organisations are able to monitor mainframe systems, custom databases, and proprietary applications as part of their compliance requirements. Hybrid environments are supported as well, allowing cloud-native and on-premise compliance data to be managed together. The system can also track custom asset types, such as specialised equipment or proprietary software, alongside standard IT assets. In addition, organisations can automate the monitoring of third-party data sources, including training records and vendor assessments. Strategic implications Secureframe expects the new capability to broaden its potential customer base, particularly among enterprises operating in regulated sectors that require complex compliance management. Custom Integrations joins other features in Secureframe's offering, such as custom frameworks, Custom Automated Tests, and Workspaces, aiming to provide flexibility to customers with various policies and requirements. Custom Integrations is available to existing Secureframe customers and can be configured through the platform's interface. Secureframe provides documentation, video tutorials, and additional support resources intended to facilitate smooth implementation by customer organisations.
Time of India
3 days ago
- Business
- Time of India
Torrent Pharma keen to break into big league
Ahmedabad-based Torrent Pharma is revving up for acquisitions in India as part of its plans to break into the top three drugmakers over a span of three to five years. Currently at seventh position by market share, Torrent has dramatically scaled up its India operations over the last five years with bolt-on deals for leading brands and small companies. For FY25, Torrent had sales of Rs 11,516 crore, of which India contributed Rs 6,393 crore. In the first media interaction following the announcement of his new role starting August 1, Aman Mehta , managing director-designate at Torrent Pharma, told ET that the commitment to the Indian market remains as strong as ever. "To be in the top three looks to be an ambitious but realistic goal," he said. "Even with some of the structural changes that are happening or have happened in the recent years, we believe that the inherent demand of the Indian pharma market is not going to change." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Villa For Sale in Dubai Might Surprise You Villas in Dubai | Search ads Learn More Undo His confidence stems from a consistent growth in the Indian market compared to those like US or Europe that have been under pressure due to regulatory challenges and a headlong drop in prices of generic drugs. On a 12-month moving annual total (MAT) basis, the Indian pharma market has grown at 7.2% to Rs 2.29 lakh crore ($26.7 billion) in May. That growth is led by a mix of drugs for cardiac issues, gastrointestinal products, anti-infectives, anti-diabetes, vitamins and respiratory issues. But for Torrent, the task to take the third rank will be a tough one. Torrent must have a faster growth rate to topple giants such as Cipla , Alkem and Intas Pharma. Sun Pharma and Abbott lead the stack as the top two in the Indian market. Live Events Torrent's deals-led growth strategy is already in play. In 2022, the company shelled out Rs 2,000 crore for private equity-backed Curatio Healthcare, makers of popular cosmetic dermatology brands. More recently in December, it lapped up a set of new generation medicines to treat diabetes from German drug maker Boehringer Ingelheim. A year later in 2023, Torrent came close to buying Cipla for an audacious $7 billion deal. Although it could not be officially confirmed, the talks failed on valuation mismatch. Torrent was also named as a frontrunner to acquire a majority stake in JB Pharma from private equity firm KKR, but that deal was also called off, at least temporarily. Mehta, who has steered most deal discussions for Torrent, says the company is at a stronger position to invest further and grow business. Sheetal Sapale, VP, PharmaTrac, a data intelligence firm that tracks medicine sales, said Torrent Pharma's revenue has grown 1.6x in the last five years, with cardiac treatments making up over a fourth of its domestic sales. She added that strategic acquisitions have helped Torrent consolidate its position in pain drugs, gastrointestinal medicines and skin care range. In the last four years, Torrent has expanded its field force. From 3,600, that may now double to 7,000 medical representatives this year, which Mehta called "methodical expansion for better territorial reach".
